GT BIOPHARMA, INC. (GTBP) Current Ratio
- Current ratio · latest quarter: Value 2.61×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 2.61× | Current assets / current liabilities. $5.79M ÷ $2.22M ≈ 2.61× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 5.79M USD | Assets, Current |
| Current obligations | 2.22M USD | Liabilities, Current |
| Cash and equivalents | 4.96M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 1.02M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.79M | $2.22M | $4.96M | (m) | (m) | (m) | $1.02M | (m) | 2.61× |
| 2026-03-31 | $10.00M | $2.42M | $8.92M | (m) | (m) | (m) | $253.00K | (m) | 4.14× |
| 2025-12-31 | $8.11M | $2.32M | $6.81M | (m) | (m) | (m) | $748.00K | (m) | 3.50× |
| 2025-09-30 | $4.32M | $1.32M | $2.53M | (m) | (m) | (m) | $769.00K | (m) | 3.27× |
| 2025-06-30 | $7.12M | $31.04M | $5.23M | (m) | (m) | (m) | $1.37M | (m) | 0.23× |
| 2025-03-31 | $2.66M | $3.64M | $2.37M | (m) | (m) | (m) | $2.38M | (m) | 0.73× |
| 2024-12-31 | $4.23M | $5.90M | $3.95M | (m) | (m) | (m) | $3.85M | (m) | 0.72× |
| 2024-09-30 | $6.76M | $4.66M | $6.42M | (m) | (m) | (m) | $2.61M | (m) | 1.45× |
| 2024-06-30 | $9.27M | $3.76M | $9.25M | (m) | (m) | (m) | $1.72M | (m) | 2.47× |
| 2024-03-31 | $9.88M | $4.60M | $1.95M | (m) | (m) | (m) | $3.21M | (m) | 2.15× |
| 2023-12-31 | $14.06M | $6.63M | $1.08M | (m) | (m) | (m) | $4.33M | (m) | 2.12× |
| 2023-09-30 | $16.05M | $5.09M | $2.65M | (m) | (m) | (m) | $3.97M | (m) | 3.15× |
| 2023-06-30 | $18.02M | $4.84M | $2.77M | (m) | (m) | (m) | $3.50M | (m) | 3.72× |
| 2023-03-31 | $19.94M | $4.08M | $2.04M | (m) | (m) | (m) | $3.13M | (m) | 4.89× |
| 2022-12-31 | $16.56M | $4.94M | $5.67M | (m) | (m) | (m) | $3.14M | (m) | 3.35× |
| 2022-09-30 | $20.87M | $5.03M | (m) | (m) | (m) | (m) | $3.33M | (m) | 4.15× |
| 2022-06-30 | $23.95M | $8.61M | (m) | (m) | (m) | (m) | $7.26M | (m) | 2.78× |
| 2022-03-31 | $27.19M | $9.50M | (m) | (m) | (m) | (m) | $8.11M | (m) | 2.86× |
| 2021-12-31 | $32.17M | $10.26M | $8.97M | (m) | (m) | (m) | $8.19M | (m) | 3.14× |
| 2021-09-30 | $35.80M | $3.92M | (m) | (m) | (m) | (m) | $2.80M | (m) | 9.13× |
| 2021-06-30 | $39.57M | $3.28M | $39.50M | (m) | (m) | (m) | $1.50M | (m) | 12.08× |
| 2021-03-31 | $27.64M | $3.63M | $27.55M | (m) | (m) | (m) | $2.38M | (m) | 7.62× |
| 2020-12-31 | $5.66M | $35.09M | (m) | (m) | (m) | (m) | $2.24M | (m) | 0.16× |
| 2020-09-30 | $833.00K | $30.69M | $350.00K | (m) | (m) | (m) | $2.17M | (m) | 0.03× |
| 2020-06-30 | $971.00K | $28.56M | $851.00K | (m) | (m) | (m) | $2.00M | (m) | 0.03× |
| 2020-03-31 | $188.00K | $21.15M | $5.00K | (m) | (m) | (m) | $2.37M | (m) | 0.01× |
| 2019-12-31 | $274.00K | $19.71M | $28.00K | (m) | (m) | (m) | $1.94M | (m) | 0.01× |
| 2019-09-30 | $337.00K | $18.77M | $313.00K | (m) | (m) | (m) | $1.72M | (m) | 0.02× |
| 2019-06-30 | $286.00K | $16.73M | $264.00K | (m) | (m) | (m) | $1.71M | (m) | 0.02× |
| 2019-03-31 | $78.00K | $15.52M | $51.00K | (m) | (m) | (m) | $1.90M | (m) | 0.01× |
| 2018-12-31 | $90.00K | $14.03M | $60.00K | (m) | (m) | (m) | $1.76M | (m) | 0.01× |
| 2018-09-30 | $1.25M | $13.22M | $1.23M | (m) | (m) | (m) | $2.25M | (m) | 0.09× |
| 2018-06-30 | $1.10M | $8.95M | $1.10M | (m) | (m) | (m) | $1.89M | (m) | 0.12× |
| 2018-03-31 | $2.87M | $5.08M | $2.87M | (m) | (m) | (m) | $1.83M | (m) | 0.57× |
| 2017-12-31 | $576.00K | $2.68M | $576.00K | (m) | (m) | (m) | $2.55M | (m) | 0.22× |
| 2017-09-30 | $2.73M | $2.80M | $2.73M | (m) | (m) | (m) | $2.71M | (m) | 0.98× |
| 2017-06-30 | $39.00K | $20.13M | $39.00K | (m) | (m) | (m) | $2.35M | (m) | 0.00× |
| 2017-03-31 | $235.00K | $18.35M | $235.00K | (m) | (m) | (m) | $2.06M | (m) | 0.01× |
| 2016-12-31 | $21.00K | $18.95M | $19.00K | (m) | (m) | (m) | $2.10M | (m) | 0.00× |
| 2016-09-30 | $156.00K | $16.97M | $154.00K | (m) | (m) | (m) | $1.81M | (m) | 0.01× |
| 2016-06-30 | $357.00K | $15.67M | $355.00K | (m) | (m) | (m) | $1.57M | (m) | 0.02× |
| 2016-03-31 | $32.00K | $19.70M | $30.00K | (m) | (m) | (m) | $1.54M | (m) | 0.00× |
| 2015-12-31 | $49.00K | $49.91M | $47.00K | (m) | (m) | (m) | $893.00K | (m) | 0.00× |
| 2015-09-30 | $44.00K | $22.31M | $42.00K | (m) | (m) | (m) | $968.00K | (m) | 0.00× |
| 2015-06-30 | $127.00K | $21.58M | $125.00K | (m) | (m) | (m) | $431.00K | (m) | 0.01× |
| 2015-03-31 | $1.42M | $50.51M | $1.42M | (m) | (m) | (m) | $256.00K | (m) | 0.03× |
| 2014-12-31 | $882.00K | $29.83M | $855.00K | (m) | (m) | (m) | $412.00K | (m) | 0.03× |
| 2014-09-30 | $690.00K | $11.31M | $664.00K | (m) | $0.00 | $26.00K | $820.00K | (m) | 0.06× |
| 2014-06-30 | $32.00K | $6.86M | $1.00K | (m) | $5.00K | $26.00K | $925.00K | (m) | 0.00× |
| 2014-03-31 | $77.00K | $6.68M | $4.00K | (m) | $30.00K | $42.00K | $935.00K | (m) | 0.01× |
| 2013-12-31 | $125.00K | $6.38M | $43.00K | (m) | $40.00K | $42.00K | $940.00K | (m) | 0.02× |
| 2013-09-30 | $40.00K | $6.03M | $0.00 | (m) | (m) | $40.00K | $935.00K | (m) | 0.01× |
| 2013-06-30 | $131.00K | $5.76M | $11.00K | (m) | (m) | $120.00K | $904.00K | (m) | 0.02× |
| 2013-03-31 | $94.00K | $5.41M | $0.00 | (m) | (m) | $94.00K | $883.00K | (m) | 0.02× |
| 2012-12-31 | $202.00K | $6.56M | $123.00K | (m) | $0.00 | $59.00K | $878.00K | (m) | 0.03× |
| 2012-09-30 | $73.00K | $6.33M | $61.00K | (m) | (m) | $0.00 | $858.00K | (m) | 0.01× |
| 2012-06-30 | $109.00K | $6.56M | $5.00K | (m) | (m) | $92.00K | $813.00K | (m) | 0.02× |
| 2012-03-31 | $144.00K | $5.43M | $120.00K | (m) | (m) | $12.00K | $815.00K | (m) | 0.03× |
| 2011-12-31 | $104.00K | $5.23M | $92.00K | (m) | (m) | $12.00K | $806.00K | (m) | 0.02× |
| 2011-09-30 | $343.00K | $5.28M | $0.00 | (m) | (m) | (m) | $974.00K | (m) | 0.06× |
| 2011-06-30 | $194.00K | $5.80M | $89.00K | (m) | (m) | (m) | $772.00K | (m) | 0.03× |
| 2010-12-31 | $137.00K | $5.65M | $54.00K | (m) | (m) | (m) | $625.00K | (m) | 0.02× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |